title: Phototherapeutic keratectomy with mitomycin C for corneal haze following photorefractive keratectomy for myopia.
abstract: OBJECTIVE
  To evaluate the safety and efficacy of phototherapeutic keratectomy (PTK) with single application of mitomycin C for patients with severe corneal haze following photorefractive keratectomy (PRK) for high myopia.
  
  
  METHODS
  Eight eyes of seven patients were treated with PTK and intraoperative topical application of mitomycin C (0.02%) for severe corneal haze (grade 3) following PRK for myopia.
  
  
  RESULTS
  All patients' visual performance improved significantly. Mean preoperative visual acuity (20/200 for both UCVA and BSCVA) improved significantly to 20/33 (0.6) and 20/30 (0.7) for UCVA and BSCVA, respectively. Six eyes (85.7%) had improved UCVA to 20/40 or better and gained five or more lines of UCVA. The corneal haze score decreased from grade 3 initially (for all eyes prior to PTK and mitomycin C) to a final mean haze score of 0.3 (range 0 to 0.5). Mean final spherical equivalent refraction achieved was -1.30 +/- 1.60 D (range -3.75 to +1.25 D). One eye gained only three lines of visual acuity due to regression and residual haze. No adverse effects related to the use of mitomycin C were recorded.
  
  
  CONCLUSIONS
  PTK with a single intraoperative application of mitomycin C was safe and effective in reducing corneal haze and improving visual acuity in patients with severe corneal haze following PRK.
authors.affiliation: Division of Ophthalmology, Sanz Medical Center, Laniado Hospital, Netanya, Israel. drporges@INetvision.net.il
authors.forename: Yair
authors.initials: Y
authors.lastname: Porges
authors.forename: Oded
authors.initials: O
authors.lastname: Ben-Haim
authors.forename: Ami
authors.initials: A
authors.lastname: Hirsh
authors.forename: Samuel
authors.initials: S
authors.lastname: Levinger
mesh_terms: D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003315:Cornea / Q000601:surgery*; D003318:Corneal Opacity / Q000188:drug therapy / Q000209:etiology / Q000601:surgery*; D005260:Female; D006801:Humans; D054018:Lasers, Excimer; D008297:Male; D008875:Middle Aged; D016685:Mitomycin / Q000627:therapeutic use*; D009216:Myopia / Q000601:surgery*; D018903:Photorefractive Keratectomy / Q000009:adverse effects*; D011183:Postoperative Complications / Q000188:drug therapy / Q000601:surgery*; D012086:Reoperation; D012449:Safety; D016896:Treatment Outcome; D014792:Visual Acuity
chemical_list: D000903:Antibiotics, Antineoplastic; D016685:Mitomycin